Physician profile
Amy Cabbabe
NPI 1023293289
$1,467.08
in general payments reported to CMS, 2019-2025
13 companies · $211 in 2025
The $211 reported for 2025 was more than what 82% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $122 · 2021: $89.85 · 2022: $550 · 2023: $164 · 2024: $227 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $602.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $450.00 | 2022 | |
| Galderma Laboratories, L.P. | $150.00 | 2023 | Dysport |
| Globus Medical, INC. | $132.06 | 2025 | Senza |
| Pacira Pharmaceuticals Incorporated | $121.84 | 2020 | |
| Davol INC. | $114.53 | 2024 | Arista Ah Flexitip |
| Novo Nordisk INC | $112.22 | 2024 | |
| Genzyme Corporation | $99.55 | 2022 | |
| Heron Therapeutics, INC. | $89.85 | 2021 | |
| Motiva USA, LLC | $79.24 | 2025 | |
| Kci USA, INC. | $66.08 | 2019 | |
| Masimo Corporation | $20.65 | 2019 | |
| Avanos Medical | $16.81 | 2019 | |
| Fisher & Paykel Healthcare INC | $14.25 | 2023 | Fisher & Paykel Healthcare |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Cabbabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.